Literature DB >> 25676516

Epidemiology of human pulmonary infection with nontuberculous mycobacteria: a review.

D Rebecca Prevots1, Theodore K Marras2.   

Abstract

Population-based data have documented a worldwide increase in the prevalence of human nontuberculous mycobacterial (NTM) infections since 2000. Mycobacterium avium complex is predominant in North America and East Asia, whereas in regions within Europe, M kansasii, M xenopi, and M malmoense are more common. Host factors important to the current epidemiology of NTM pulmonary disease include thoracic skeletal abnormalities, rheumatoid arthritis, and use of immunomodulatory drugs. Clustering of disease within families suggests a heritable genetic predisposition to disease susceptibility. Warm, humid environments with high atmospheric vapor pressure contribute to population risk. Published by Elsevier Inc.

Entities:  

Keywords:  Epidemiology; Global; Nontuberculous mycobacteria; Pulmonary disease

Mesh:

Year:  2014        PMID: 25676516      PMCID: PMC4332564          DOI: 10.1016/j.ccm.2014.10.002

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  88 in total

1.  Management of opportunist mycobacterial infections: Joint Tuberculosis Committee Guidelines 1999. Subcommittee of the Joint Tuberculosis Committee of the British Thoracic Society.

Authors: 
Journal:  Thorax       Date:  2000-03       Impact factor: 9.139

2.  Specific HLA in pulmonary MAC infection in a Japanese population.

Authors:  M Takahashi; A Ishizaka; H Nakamura; K Kobayashi; M Nakamura; M Namiki; T Sekita; S Okajima
Journal:  Am J Respir Crit Care Med       Date:  2000-07       Impact factor: 21.405

3.  Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis.

Authors:  Kenneth N Olivier; David J Weber; Richard J Wallace; Ali R Faiz; Ji-Hyun Lee; Yansheng Zhang; Barbara A Brown-Elliot; Allison Handler; Rebecca W Wilson; Michael S Schechter; Lloyd J Edwards; Subha Chakraborti; Michael R Knowles
Journal:  Am J Respir Crit Care Med       Date:  2002-11-14       Impact factor: 21.405

Review 4.  Epidemiology of human pulmonary infection with nontuberculous mycobacteria.

Authors:  Theodore K Marras; Charles L Daley
Journal:  Clin Chest Med       Date:  2002-09       Impact factor: 2.878

5.  Sentinel-site surveillance of Mycobacterium avium complex pulmonary disease.

Authors:  J Maugein; M Dailloux; B Carbonnelle; V Vincent; J Grosset
Journal:  Eur Respir J       Date:  2005-12       Impact factor: 16.671

6.  Analysis of HLA antigens in Mycobacterium avium-intracellulare pulmonary infection.

Authors:  K Kubo; Y Yamazaki; M Hanaoka; H Nomura; K Fujimoto; T Honda; M Ota; Y Kamijou
Journal:  Am J Respir Crit Care Med       Date:  2000-04       Impact factor: 21.405

7.  Nontuberculous mycobacteria: incidence in Southwest Ireland from 1987 to 2000.

Authors:  M P Kennedy; T M O'Connor; C Ryan; S Sheehan; B Cryan; C Bredin
Journal:  Respir Med       Date:  2003-03       Impact factor: 3.415

8.  Nontuberculous mycobacteria in non-HIV patients: epidemiology, treatment and response.

Authors:  M T Henry; L Inamdar; D O'Riordain; M Schweiger; J P Watson
Journal:  Eur Respir J       Date:  2004-05       Impact factor: 16.671

9.  National atypical mycobacteria survey, 2000.

Authors:  Frank Haverkort
Journal:  Commun Dis Intell Q Rep       Date:  2003

10.  Clinical significance of nontuberculous mycobacteria isolated from respiratory specimens in Korea.

Authors:  Won-Jung Koh; O Jung Kwon; Kyeongman Jeon; Tae Sung Kim; Kyung Soo Lee; Young Kil Park; Gill Han Bai
Journal:  Chest       Date:  2006-02       Impact factor: 9.410

View more
  232 in total

1.  Whole-Exome Sequencing Identifies the 6q12-q16 Linkage Region and a Candidate Gene, TTK, for Pulmonary Nontuberculous Mycobacterial Disease.

Authors:  Fei Chen; Eva P Szymanski; Kenneth N Olivier; Xinyue Liu; Hervé Tettelin; Steven M Holland; Priya Duggal
Journal:  Am J Respir Crit Care Med       Date:  2017-12-15       Impact factor: 21.405

Review 2.  Surgical management of non-cystic fibrosis bronchiectasis.

Authors:  Miyako Hiramatsu; Yuji Shiraishi
Journal:  J Thorac Dis       Date:  2018-10       Impact factor: 2.895

3.  Intermittent Treatment with Azithromycin and Ethambutol for Noncavitary Mycobacterium avium Complex Pulmonary Disease.

Authors:  Seong Mi Moon; In Young Yoo; Hee Jae Huh; Nam Yong Lee; Byung Woo Jhun
Journal:  Antimicrob Agents Chemother       Date:  2019-12-20       Impact factor: 5.191

Review 4.  Macrophage Signaling Pathways in Pulmonary Nontuberculous Mycobacteria Infections.

Authors:  Zohra Prasla; Roy L Sutliff; Ruxana T Sadikot
Journal:  Am J Respir Cell Mol Biol       Date:  2020-08       Impact factor: 6.914

5.  Clinical Characteristics and Treatment Outcomes of Patients with Acquired Macrolide-Resistant Mycobacterium abscessus Lung Disease.

Authors:  Hayoung Choi; Su-Young Kim; Dae Hun Kim; Hee Jae Huh; Chang-Seok Ki; Nam Yong Lee; Seung-Heon Lee; Soyoun Shin; Sung Jae Shin; Charles L Daley; Won-Jung Koh
Journal:  Antimicrob Agents Chemother       Date:  2017-09-22       Impact factor: 5.191

6.  Advancing Translational Science for Pulmonary Nontuberculous Mycobacterial Infections. A Road Map for Research.

Authors:  Shelby Daniel-Wayman; Getahun Abate; Daniel L Barber; Luiz E Bermudez; Rhea N Coler; Michael H Cynamon; Charles L Daley; Rebecca M Davidson; Thomas Dick; R Andres Floto; Emily Henkle; Steven M Holland; Mary Jackson; Richard E Lee; Eric L Nuermberger; Kenneth N Olivier; Diane J Ordway; D Rebecca Prevots; James C Sacchettini; Max Salfinger; Christopher M Sassetti; Christine F Sizemore; Kevin L Winthrop; Adrian M Zelazny
Journal:  Am J Respir Crit Care Med       Date:  2019-04-15       Impact factor: 21.405

7.  Clofazimine for the Treatment of Mycobacterium kansasii.

Authors:  Shashikant Srivastava; Tawanda Gumbo
Journal:  Antimicrob Agents Chemother       Date:  2018-07-27       Impact factor: 5.191

8.  Clofazimine-Containing Regimen for the Treatment of Mycobacterium abscessus Lung Disease.

Authors:  Bumhee Yang; Byung Woo Jhun; Seong Mi Moon; Hyun Lee; Hye Yun Park; Kyeongman Jeon; Dae Hun Kim; Su-Young Kim; Sung Jae Shin; Charles L Daley; Won-Jung Koh
Journal:  Antimicrob Agents Chemother       Date:  2017-05-24       Impact factor: 5.191

9.  Clinical Characteristics, Treatment Outcomes, and Resistance Mutations Associated with Macrolide-Resistant Mycobacterium avium Complex Lung Disease.

Authors:  Seong Mi Moon; Hye Yun Park; Su-Young Kim; Byung Woo Jhun; Hyun Lee; Kyeongman Jeon; Dae Hun Kim; Hee Jae Huh; Chang-Seok Ki; Nam Yong Lee; Hong Kwan Kim; Yong Soo Choi; Jhingook Kim; Seung-Heon Lee; Chang Ki Kim; Sung Jae Shin; Charles L Daley; Won-Jung Koh
Journal:  Antimicrob Agents Chemother       Date:  2016-10-21       Impact factor: 5.191

10.  Patient-Centered Research Priorities for Pulmonary Nontuberculous Mycobacteria (NTM) Infection. An NTM Research Consortium Workshop Report.

Authors:  Emily Henkle; Timothy Aksamit; Alan Barker; Charles L Daley; David Griffith; Philip Leitman; Amy Leitman; Elisha Malanga; Theodore K Marras; Kenneth N Olivier; D Rebecca Prevots; Delia Prieto; Alexandra L Quittner; William Skach; John W Walsh; Kevin L Winthrop
Journal:  Ann Am Thorac Soc       Date:  2016-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.